Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Current or prospective ownership or investment interest | $102,484 | 3 | 88.4% |
| Acquisitions | $10,961 | 3 | 9.5% |
| Consulting Fee | $1,875 | 1 | 1.6% |
| Food and Beverage | $611.88 | 9 | 0.5% |
| Unspecified | $0 | 8 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $113,445 | 6 | $0 (2023) |
| INSTYLLA INC. | $1,894 | 2 | $0 (2021) |
| Teleflex LLC | $448.86 | 5 | $0 (2023) |
| Astellas Pharma US Inc | $89.05 | 2 | $0 (2024) |
| HealthTronics Mobile Solutions, LLC | $54.67 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18.67 | 2 | Astellas Pharma US Inc ($18.67) |
| 2023 | $1,801 | 4 | Boston Scientific Corporation ($1,607) |
| 2022 | $6,195 | 3 | BOSTON SCIENTIFIC CORPORATION ($6,072) |
| 2021 | $5,309 | 6 | Boston Scientific Corporation ($3,282) |
| 2020 | $7,115 | 2 | Boston Scientific Corporation ($7,115) |
| 2019 | $125.05 | 3 | Astellas Pharma US Inc ($70.38) |
| 2018 | $95,369 | 3 | BOSTON SCIENTIFIC CORPORATION ($95,369) |
| 2017 | $0 | 1 | Applied Medical Corporation |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/19/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Oncology | ||||||
| 2024 | Applied Medical Corporation | — | — | — | $0.00 | Ownership |
| 06/14/2023 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $152.40 | General |
| Category: Interventional Urology | ||||||
| 06/13/2023 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $41.57 | General |
| Category: Interventional Urology | ||||||
| 05/25/2023 | Boston Scientific Corporation | — | Acquisitions | In-kind items and services | $1,607.43 | General |
| Category: General - Therapies_URO | ||||||
| 2023 | Applied Medical Corporation | — | — | — | $0.00 | Ownership |
| 05/11/2022 | Teleflex LLC | UroLift System (Device) | Food and Beverage | In-kind items and services | $122.22 | General |
| Category: Interventional Urology | ||||||
| 03/21/2022 | BOSTON SCIENTIFIC CORPORATION | General - Therapies (Device) | Acquisitions | Cash or cash equivalent | $6,072.39 | General |
| Category: THERAPIES | ||||||
| 2022 | Applied Medical Corporation | — | — | — | $0.00 | Ownership |
| 11/17/2021 | INSTYLLA INC. | HES Embrace (Device), Verge MC System, Instylla Delivery Kit | Consulting Fee | Cash or cash equivalent | $1,875.00 | General |
| Category: Liquid Embolics for Interventional Radiology | ||||||
| 10/20/2021 | INSTYLLA INC. | — | Food and Beverage | In-kind items and services | $19.30 | General |
| 09/24/2021 | Teleflex LLC | UroLift System (Device) | Food and Beverage | In-kind items and services | $114.70 | General |
| Category: Interventional Urology | ||||||
| 09/23/2021 | Teleflex LLC | UroLift System (Device) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Interventional Urology | ||||||
| 03/09/2021 | Boston Scientific Corporation | GENERAL THERAPIES (Device) | Acquisitions | Cash or cash equivalent | $3,281.64 | General |
| Category: PAIN MANAGEMENT | ||||||
| 2021 | Applied Medical Corporation | — | — | — | $0.00 | Ownership |
| 03/13/2020 | Boston Scientific Corporation | GENERAL - THERAPIES (Device) | Current or prospective ownership or investment interest | In-kind items and services | $7,114.67 | General |
| Category: THERAPIES | ||||||
| 2020 | Applied Medical Corporation | — | — | — | $0.00 | Ownership |
| 10/04/2019 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $70.38 | General |
| Category: ONCOLOGY | ||||||
| 03/15/2019 | HealthTronics Mobile Solutions, LLC | Mobile Cryoblation Services (Device) | Food and Beverage | Cash or cash equivalent | $54.67 | General |
| Category: Cryoblation Probe | ||||||
| 2019 | Applied Medical Corporation | — | — | — | $0.00 | Ownership |
| 12/24/2018 | BOSTON SCIENTIFIC CORPORATION | GENERAL THERAPIES (Device) | Current or prospective ownership or investment interest | In-kind items and services | $148.37 | General |
| Category: THERAPIES | ||||||
| 10/16/2018 | BOSTON SCIENTIFIC CORPORATION | GENERAL THERAPIES (Device) | Current or prospective ownership or investment interest | In-kind items and services | $95,220.56 | General |
| Category: THERAPIES | ||||||
| 2018 | Applied Medical Corporation | — | — | — | $0.00 | Ownership |
| 2017 | Applied Medical Corporation | — | — | — | $0.00 | Ownership |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 5 | 577 | 671 | $76,865 | $20,605 |
| 2021 | 9 | 825 | 993 | $132,005 | $35,568 |
| 2020 | 7 | 669 | 751 | $93,369 | $20,025 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 212 | 259 | $47,625 | $12,634 | 26.5% |
| 76857 | Limited ultrasound scan of pelvis | Facility | 2022 | 187 | 218 | $14,263 | $3,843 | 26.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 45 | 45 | $10,260 | $2,838 | 27.7% |
| 51741 | Electronic assessment of bladder emptying | Facility | 2022 | 114 | 128 | $3,072 | $794.34 | 25.9% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Facility | 2022 | 19 | 21 | $1,645 | $495.88 | 30.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 262 | 341 | $55,869 | $17,131 | 30.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Facility | 2021 | 86 | 86 | $18,768 | $5,463 | 29.1% |
| 76857 | Ultrasound of pelvis, limited, not pregnancy related | Facility | 2021 | 242 | 298 | $21,213 | $5,374 | 25.3% |
| 55700 | Biopsy of prostate gland | Facility | 2021 | 22 | 22 | $7,920 | $2,494 | 31.5% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Facility | 2021 | 18 | 26 | $5,778 | $1,609 | 27.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 14 | 16 | $3,920 | $1,299 | 33.1% |
| 51741 | Electronic assessment of bladder emptying | Facility | 2021 | 138 | 155 | $14,407 | $971.20 | 6.7% |
| 76775 | Ultrasound behind abdominal cavity, limited | Facility | 2021 | 21 | 27 | $2,240 | $633.08 | 28.3% |
| 76942 | Ultrasonic guidance imaging supervision and interpretation for insertion of needle | Facility | 2021 | 22 | 22 | $1,890 | $592.68 | 31.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 210 | 247 | $34,639 | $8,247 | 23.8% |
| 76857 | Ultrasound of pelvis | Facility | 2020 | 183 | 208 | $14,352 | $3,425 | 23.9% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Facility | 2020 | 48 | 48 | $9,984 | $2,624 | 26.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 54 | 56 | $5,990 | $2,268 | 37.9% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Facility | 2020 | 18 | 24 | $5,435 | $1,579 | 29.1% |
| 76775 | Ultrasound behind abdominal cavity, limited | Facility | 2020 | 25 | 29 | $2,314 | $636.49 | 27.5% |
| 51741 | Electronic assessment of bladder emptying | Facility | 2020 | 107 | 115 | $18,975 | $628.58 | 3.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 24 | 24 | $1,680 | $616.44 | 36.7% |
About Dr. Richard Babayan, M.D
Dr. Richard Babayan, M.D is a Urology healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1396717120.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Babayan, M.D has received a total of $115,932 in payments from pharmaceutical and medical device companies, with $18.67 received in 2024. These payments were reported across 24 transactions from 6 companies. The most common payment nature is "Current or prospective ownership or investment interest" ($102,484).
As a Medicare-enrolled provider, Babayan has provided services to 2,071 Medicare beneficiaries, totaling 2,415 services with total Medicare billing of $76,197. Data is available for 3 years (2020–2022), covering 22 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Boston, MA
- Active Since 02/06/2006
- Last Updated 04/23/2021
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1396717120
Products in Payments
- GENERAL THERAPIES (Device) $95,369
- GENERAL - THERAPIES (Device) $7,115
- General - Therapies (Device) $6,072
- GENERAL THERAPIES (Device) $3,282
- HES Embrace (Device) $1,875
- UroLift System (Device) $254.89
- UROLIFT (Device) $193.97
- XTANDI (Drug) $70.38
- Mobile Cryoblation Services (Device) $54.67
- Xtandi (Drug) $18.67
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Boston
Dr. Christopher Cutie, Md, MD
Urology — Payments: $3.8M
Brian Eisner, Md, MD
Urology — Payments: $594,130
Tony Luongo, Md, MD
Urology — Payments: $531,062
Dr. Shahin Tabatabaei, Md, MD
Urology — Payments: $165,699
Ricardo Munarriz, M.d, M.D
Urology — Payments: $138,151
Dr. Adam Kibel, Md, MD
Urology — Payments: $113,326